finance.yahoo.com ·
Jim Cramer Left Stunned Unitedhealth
Topic context
This topic has been covered 352601 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe article covers UnitedHealth's stock performance driven by analyst upgrades and a CMS payment rate increase for Medicare Advantage. The commercial mechanism is a regulatory-driven revenue boost for insurers like UnitedHealth, improving margin outlook. Impact is company-specific and US-focused, with no direct commodity or supply chain effects.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- UnitedHealth stock up 43.6% over past year, 17% YTD
- JPMorgan raised price target from $389 to $420, Overweight
- Goldman Sachs reaffirmed Buy, target $435, added to US Conviction List
- CMS announced 2.48% Medicare Advantage payment increase for 2027
- Jim Cramer highlighted UnitedHealth's strong performance in healthcare insurance
Managed care margins may expand 50-100bps over 1-4 weeks as higher Medicare rates flow through.
Sign in to see all sector verdicts, full thesis and counter-argument debate.
Sector impact at a glance
- GLOBAL_HEALTHCAREmid
Related stories
finance.yahoo.com
Eurodry Edry Q1 2026 Earnings
zerohedge.com
Europe Primed Lower Open Amid Lack Progress Usiran Hefty Speaker Slate Nvidia Earnings Due
finance.yahoo.com
Aytu Aytu Q3 2026 Earnings
auto.economictimes.indiatimes.com
Petrol Diesel Prices Hiked by 3 Per Litre Effective Immediately Check Rates in Your City
fool.com